When did FibroBiologics (FBLG) last report earnings?

FibroBiologics last reported on Jul 31, 2025, covering fiscal Q2 2025.

Did FBLG beat earnings estimates?

FibroBiologics reported EPS of −$2.40 for Q2 2025, in line with the −$2.40 consensus estimate.

FibroBiologics (FBLG) earnings history

Most recent quarter

Fiscal period: Q2 2025
Period end: Jun 30, 2025
EPS actual: −$2.40
EPS estimate: −$2.40
EPS surprise: +0.00%
Revenue surprise: +0.00%
Revenue: $0.00
Revenue estimate: $0.00
Reported: Jul 31, 2025
SEC filing: View filing

Earnings history

Period	Reported	EPS estimate	EPS actual	Surprise	Revenue	Filing
Q2 2025	Jul 31, 2025	−$2.40	−$2.40	+0.00%	$0.00	SEC
Q1 2025	May 14, 2025	−$2.50	−$2.80	−12.00%	$0.00	SEC
Q4 2024	Mar 31, 2025	−$1.84	−$1.80	+2.17%	$0.00	SEC
Q2 2024	Aug 7, 2024	$0.60	$0.60	+0.00%	$0.00	SEC

Quarterly revenue

Q2 2024

$0.00

Q4 2024

$0.00

Q1 2025

$0.00

Q2 2025

$0.00

Frequently asked questions

When did FibroBiologics (FBLG) last report earnings?
FibroBiologics last reported on Jul 31, 2025, covering fiscal Q2 2025.
Did FBLG beat earnings estimates?
FibroBiologics reported EPS of −$2.40 for Q2 2025, in line with the −$2.40 consensus estimate.

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by